Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Kashihara

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Microcirculation (New York, N.Y. : 1994)|October 10, 2013
Angiotensin II regulates islet microcirculation and insulin secretion in miceChieko Ihoriya, Minoru Satoh, Atsunori Kuwabara, et al.
Kidney International Reports|September 14, 2019
Hyperkalemia in Real-World Patients Under Continuous Medical Care in JapanNaoki Kashihara, Shun Kohsaka, Eiichiro Kanda, et al.
Scientific Reports|January 18, 2024
New marker for chronic kidney disease progression and mortality in medical-word virtual spaceEiichiro Kanda, Bogdan I Epureanu, Taiji Adachi, et al.
Plos One|March 13, 2024
Mathematical expansion and clinical application of chronic kidney disease stage as vector fieldEiichiro Kanda, Bogdan I Epureanu, Taiji Adachi, et al.
Arthritis and Rheumatism|March 10, 2010
Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockersTakeo Sakuta, Yoshitaka Morita, Minoru Satoh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2015
Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in miceHiroyuki Kadoya, Minoru Satoh, Tamaki Sasaki, et al.
Nephrology (Carlton, Vic.)|June 22, 2017
Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general populationTomoko Usui, Eiichiro Kanda, Chiho Iseki, et al.
Clinical Kidney Journal|May 7, 2021
Roxadustat and thyroid-stimulating hormone suppressionAtsuyuki Tokuyama, Hiroyuki Kadoya, Atsushi Obata, et al.
BMC Nephrology|December 20, 2023
IL-1β may be an indicator of peritoneal deterioration after healing of peritoneal dialysis-associated peritonitisAkira Hirano, Hiroyuki Kadoya, Yu Yamanouchi, et al.
Clinical and Experimental Nephrology|October 8, 2023
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m<sup>2</sup> in the J-DREAMS cohortYuka Sugawara, Eiichiro Kanda, Mitsuru Ohsugi, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Microcirculation (New York, N.Y. : 1994)|October 10, 2013
Angiotensin II regulates islet microcirculation and insulin secretion in miceChieko Ihoriya, Minoru Satoh, Atsunori Kuwabara, et al.
Kidney International Reports|September 14, 2019
Hyperkalemia in Real-World Patients Under Continuous Medical Care in JapanNaoki Kashihara, Shun Kohsaka, Eiichiro Kanda, et al.
Scientific Reports|January 18, 2024
New marker for chronic kidney disease progression and mortality in medical-word virtual spaceEiichiro Kanda, Bogdan I Epureanu, Taiji Adachi, et al.
Plos One|March 13, 2024
Mathematical expansion and clinical application of chronic kidney disease stage as vector fieldEiichiro Kanda, Bogdan I Epureanu, Taiji Adachi, et al.
Arthritis and Rheumatism|March 10, 2010
Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockersTakeo Sakuta, Yoshitaka Morita, Minoru Satoh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2015
Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in miceHiroyuki Kadoya, Minoru Satoh, Tamaki Sasaki, et al.
Nephrology (Carlton, Vic.)|June 22, 2017
Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general populationTomoko Usui, Eiichiro Kanda, Chiho Iseki, et al.
Clinical Kidney Journal|May 7, 2021
Roxadustat and thyroid-stimulating hormone suppressionAtsuyuki Tokuyama, Hiroyuki Kadoya, Atsushi Obata, et al.
BMC Nephrology|December 20, 2023
IL-1β may be an indicator of peritoneal deterioration after healing of peritoneal dialysis-associated peritonitisAkira Hirano, Hiroyuki Kadoya, Yu Yamanouchi, et al.
Clinical and Experimental Nephrology|October 8, 2023
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m<sup>2</sup> in the J-DREAMS cohortYuka Sugawara, Eiichiro Kanda, Mitsuru Ohsugi, et al.
Pageof 21